All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma

NCT06158412 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma in Relapse
Multiple Myeloma, Refractory

Interventions

DRUG: All-trans Retinoic Acid in combination with the KPD Regimen

Sponsor

The First Affiliated Hospital of Xiamen University